High Vista Strategies LLC Janux Therapeutics, Inc. Transaction History
High Vista Strategies LLC
- $242 Million
- Q4 2024
A detailed history of High Vista Strategies LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 69,715 shares of JANX stock, worth $2.11 Million. This represents 1.54% of its overall portfolio holdings.
Number of Shares
69,715
Previous 23,472
197.01%
Holding current value
$2.11 Million
Previous $1.07 Million
250.09%
% of portfolio
1.54%
Previous 0.42%
Shares
3 transactions
Others Institutions Holding JANX
# of Institutions
229Shares Held
55.2MCall Options Held
687KPut Options Held
357K-
Ra Capital Management, L.P. Boston, MA10.4MShares$313 Million8.99% of portfolio
-
Janus Henderson Group PLC London, X03.56MShares$108 Million0.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.52MShares$106 Million7.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.06MShares$92.5 Million0.3% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$70.8 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.26B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...